Table: Rohto -2023/24 parent results

Rohto Pharmaceutical

13/05/2024 07:00

May 13 (Reuters)- 
          Rohto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2024    Mar 31, 2023   Mar 31, 2025     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            128.94          115.36                                
                 (+11.8 pct)     (+14.0 pct)                             
  Operating         21.43           18.61                                
                 (+15.2 pct)     (+11.3 pct)                             
  Recurring         26.70           22.46                                
                 (+18.9 pct)     (+28.2 pct)                             
  Net               19.97           16.57                                
                 (+20.5 pct)     (+27.1 pct)                             
  EPS             87.54 yen       72.62 yen                              
  EPS Diluted     87.28 yen       72.42 yen                              
  Ann Div         27.00 yen                      30.00 yen               
  -Q2 Div         12.00 yen       20.00 yen      15.00 yen               
  -Q4 Div         15.00 yen       12.00 yen      15.00 yen               
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T